These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 28298171)

  • 41. Multi-kinetics and site-specific release of gabapentin and flurbiprofen from oral fixed-dose combination: in vitro release and in vivo food effect.
    Sonvico F; Conti C; Colombo G; Buttini F; Colombo P; Bettini R; Barchielli M; Leoni B; Loprete L; Rossi A
    J Control Release; 2017 Sep; 262():296-304. PubMed ID: 28774840
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of microenvironment pH of swellable and erodable buffered matrices on the release characteristics of diclofenac sodium.
    Al-Taani BM; Tashtoush BM
    AAPS PharmSciTech; 2003; 4(3):E43. PubMed ID: 14621975
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The Properties of HPMC:PEO Extended Release Hydrophilic Matrices and their Response to Ionic Environments.
    Hu A; Chen C; Mantle MD; Wolf B; Gladden LF; Rajabi-Siahboomi A; Missaghi S; Mason L; Melia CD
    Pharm Res; 2017 May; 34(5):941-956. PubMed ID: 27633887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The consequence of the chemical composition of HPMC in matrix tablets on the release behaviour of model drug substances having different solubility.
    Viridén A; Wittgren B; Larsson A
    Eur J Pharm Biopharm; 2011 Jan; 77(1):99-110. PubMed ID: 21081160
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro/in vivo evaluation of two series of TA-5707F controlled release matrix tablets prepared with hydroxypropyl methyl cellulose derivatives with entero-soluble or gel-formation properties.
    Yamakita H; Maejima T; Osawa T
    Biol Pharm Bull; 1995 Oct; 18(10):1409-16. PubMed ID: 8593447
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does the performance of wet granulation and tablet hardness affect the drug dissolution profile of carvedilol in matrix tablets?
    Košir D; Ojsteršek T; Vrečer F
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1543-1550. PubMed ID: 29848075
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation and in vitro evaluation of controlled release hydrophilic matrix tablets of ketorolac tromethamine using factorial design.
    Genç L; Jalvand E
    Drug Dev Ind Pharm; 2008 Aug; 34(8):903-10. PubMed ID: 18686094
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Release characteristics and in vitro-in vivo correlation of pulsatile pattern for a pulsatile drug delivery system activated by membrane rupture via osmotic pressure and swelling.
    Lin HL; Lin SY; Lin YK; Ho HO; Lo YW; Sheu MT
    Eur J Pharm Biopharm; 2008 Sep; 70(1):289-301. PubMed ID: 18539015
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol:
    Sweed NM; Basalious EB; Nour SA
    Drug Dev Ind Pharm; 2019 Nov; 45(11):1777-1787. PubMed ID: 31418598
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Interaction between fed gastric media (Ensure Plus®) and different hypromellose based caffeine controlled release tablets: comparison and mechanistic study of caffeine release in fed and fasted media versus water using the USP dissolution apparatus 3.
    Franek F; Holm P; Larsen F; Steffansen B
    Int J Pharm; 2014 Jan; 461(1-2):419-26. PubMed ID: 24342711
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In Vitro and In Vivo Modeling of Hydroxypropyl Methylcellulose (HPMC) Matrix Tablet Erosion Under Fasting and Postprandial Status.
    Guiastrennec B; Söderlind E; Richardson S; Peric A; Bergstrand M
    Pharm Res; 2017 Apr; 34(4):847-859. PubMed ID: 28155077
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The influence of hydro-alcoholic media on hypromellose matrix systems.
    Levina M; Vuong H; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2007 Oct; 33(10):1125-34. PubMed ID: 17963114
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of Hydrophilic Polymers on the Release Rate and Pharmacokinetics of Acyclovir Tablets Obtained by Wet Granulation: In Vitro and In Vivo Assays.
    Venkatesh DN; Meyyanathan SN; Kovacevic A; Zielińska A; Fonseca J; Eder P; Dobrowolska A; Souto EB
    Molecules; 2022 Oct; 27(19):. PubMed ID: 36235026
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Formulation and optimization of a sustained-release tablet of ketorolac tromethamine.
    Vatsaraj N; Zia H; Needham T
    Drug Deliv; 2002; 9(3):153-9. PubMed ID: 12396732
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thermogravimetric investigation of the hydration behaviour of hydrophilic matrices.
    Segale L; Giovannelli L; Pattarino F; Conti S; Maggi L; Grenier P; Vergnault G
    J Pharm Sci; 2010 Apr; 99(4):2070-9. PubMed ID: 19780132
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ; Windberg-Baarup A; Neri C; Byway PV; Booth SW; Fitzpatrick S
    Int J Pharm; 2007 Jun; 337(1-2):246-53. PubMed ID: 17306477
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous probing of swelling, erosion and dissolution by NMR-microimaging--effect of solubility of additives on HPMC matrix tablets.
    Tajarobi F; Abrahmsén-Alami S; Carlsson AS; Larsson A
    Eur J Pharm Sci; 2009 May; 37(2):89-97. PubMed ID: 19429415
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of gastrointestinal transit on micro-environmental pH inside HPMC matrix tablets - in vitro study.
    Vrbanac H; Trontelj J; Osojnik A; Berginc K; Janković B
    Int J Pharm; 2021 Jul; 604():120718. PubMed ID: 34048929
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Determining the polymer threshold amount for achieving robust drug release from HPMC and HPC matrix tablets containing a high-dose BCS class I model drug: in vitro and in vivo studies.
    Klančar U; Baumgartner S; Legen I; Smrdel P; Kampuš NJ; Krajcar D; Markun B; Kočevar K
    AAPS PharmSciTech; 2015 Apr; 16(2):398-406. PubMed ID: 25331194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.